A developed and validated centrifugal ultrafiltration coupled with high performance liquid chromatography-tandem mass spectrometry method for rapid quantification of unbound lenvatinib in human plasma
- 14 May 2024
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1240, 124157
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasmaBiochemical and Biophysical Research Communications, 2023
- Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinomaCancer Chemotherapy and Pharmacology, 2021
- Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinomaCancer Chemotherapy and Pharmacology, 2020
- Determination of unbound valproic acid in plasma using centrifugal ultrafiltration and gas chromatography:Application in TDMAnalytical Biochemistry, 2020
- Analysis of endocannabinoids in plasma samples by biocompatible solid-phase microextraction devices coupled to mass spectrometryAnalytica Chimica Acta, 2019
- Minimal impact of hepatic and renal impairment on plasma protein binding of lenvatinib, and identification of its major plasma binding proteinBiopharmaceutics & Drug Disposition, 2019
- Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methodsClinica Chimica Acta, 2018
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase InhibitorEuropean Journal of Drug Metabolism and Pharmacokinetics, 2017
- Accuracy assessment on the analysis of unbound drug in plasma by comparing traditional centrifugal ultrafiltration with hollow fiber centrifugal ultrafiltration and application in pharmacokinetic studyJournal of Chromatography A, 2013
- Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient managementClinica Chimica Acta, 2007